Valuation: Biogen Inc.

Market Cap 29.99B 26.28B 24.4B 22.42B 42.25B 2,894B 42.87B 291B 114B 1,416B 113B 110B 4,892B P/E 2026 *
24.7x
P/E 2027 * 16.2x
Enterprise Value 35.31B 30.94B 28.72B 26.39B 49.73B 3,407B 50.46B 342B 134B 1,667B 133B 130B 5,759B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 3.22x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.93%
1 week+2.39%
Current month-6.53%
1 month+1.12%
3 months+6.25%
6 months+16.20%
Current year+14.75%
1 week 194.67
Extreme 194.6725
215.79
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 124.56
Extreme 124.5561
219.72
3 years 110.04
Extreme 110.035
280.42
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2020-12-31
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Date Insider Type Main position Quantity % Market Cap.
6/9/26 Free

Director

1,505 0.0010%
6/9/26 Free

Director

1,505 0.0010%
6/9/26 Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%+2.39%+57.96%-27.09% 29.99B
-2.41%-0.21%+18.21%-8.81% 68.69B
-0.25%+3.22%+41.00%+198.82% 52.97B
-1.65%+37.20%+37.20%+37.20% 43.61B
-2.83%-4.08%-53.81%-55.84% 40.75B
-1.63%-13.22%+81.03%-51.83% 23.67B
-0.24%+2.03%+70.43%+85.04% 23.45B
+0.11%+2.44%+4.06%+181.25% 20.46B
-0.39%+1.58%+71.18%+126.61% 16.66B
+0.02%-0.29%+80.07%+147.95% 16.16B
Average -1.00%+0.41%+40.73%+63.33% 33.64B
Weighted average by Cap. -1.29%+1.07%+31.88%+51.83%

Financials

2026 *2027 *
Net sales 10.08B 8.83B 8.2B 7.53B 14.19B 972B 14.4B 97.65B 38.22B 476B 37.83B 37.01B 1,644B 10.33B 9.05B 8.4B 7.72B 14.55B 997B 14.76B 100B 39.18B 488B 38.78B 37.94B 1,685B
Net income 1.29B 1.13B 1.05B 964M 1.82B 124B 1.84B 12.49B 4.89B 60.87B 4.84B 4.73B 210B 1.99B 1.74B 1.62B 1.48B 2.8B 192B 2.84B 19.25B 7.53B 93.79B 7.46B 7.3B 324B
Net Debt 5.32B 4.66B 4.32B 3.97B 7.49B 513B 7.6B 51.51B 20.16B 251B 19.95B 19.52B 867B 3.23B 2.83B 2.63B 2.41B 4.55B 311B 4.61B 31.27B 12.24B 152B 12.11B 11.85B 526B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
26-07-22 $200.45 -1.33% 200,129
26-07-21 $203.16 +1.61% 652,841
26-07-20 $199.95 -2.93% 963,088
26-07-17 $205.99 -1.40% 1,151,283
26-07-16 $208.92 +5.92% 1,872,778
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
203.16USD
Average target price
227.59USD
Spread / Average Target
+12.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock